Sevelamer Carbonate
Product Images NDC 10135-660

4 FDA label images from Marlex Pharmaceuticals Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 10135-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Chemical Structure Of Sevelamer Carbonate (Sevelamer Carbonate 01)

Figure 1. Chemical Structure Of Sevelamer Carbonate (Sevelamer Carbonate 01)
Chemical structure of Sevelamer Carbonate showing its polymeric composition with repeating units containing amine and hydroxyl groups along with bicarbonate (HCO3-) and ammonium (NH3+) components, as depicted in the diagram.*
FDA Label Image

Figure 3. Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis. (Sevelamer Carbonate 02)

Figure 3. Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis. (Sevelamer Carbonate 02)
A graph depicting the percentage of patients with a reduction of serum phosphorus by 2 or more units on the y-axis, plotted against reduction in serum phosphorus (mg/dL) on the x-axis. It compares two groups: Sevelamer Hydrochloride and Active Control, showing their relative changes in serum phosphorus levels from baseline.*
FDA Label Image

Figure 4. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Sevelamer Carbonate 03)

Figure 4. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Sevelamer Carbonate 03)
A line graph showing phosphorus change from baseline over a 52-week study period. It compares Sevelamer Hydrochloride and an Active-Control group, with phosphorus change values on the vertical axis and study weeks on the horizontal axis. The graph illustrates trends of phosphorus decrease and stabilization for both treatments across the study duration.*
FDA Label Image

Principal Display Panelndc 10135-0660-68sevelamer Carbonatetablets800 mg270 Tabletsrx Only (Sevelamer Carbonate 04)

Principal Display Panelndc 10135-0660-68sevelamer Carbonatetablets800 mg270 Tabletsrx Only (Sevelamer Carbonate 04)
Label for Sevelamer Carbonate Tablets 800 mg by Marlex Pharmaceuticals, Inc. The label states the product contains 270 tablets, is Rx only, and lists active and inactive ingredients. Storage instructions and manufacturer details in New Castle, DE are included along with a barcode and NDC number 10135-0660-68.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.